Literature DB >> 9026355

Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain.

R M O'Leary1, S P Gallagher, B O'Connor.   

Abstract

Prolyl endopeptidase has been predominantly described as a cytosolic activity capable of cleaving a number of important neuropeptides (including TRH, LHRH, Bradykinin, Angiotensin, Substance P, Neurotensin, Oxytocin and Vasopressin) on the carboxy side of proline. In this paper, we report, for the first time, on the complete purification and characterization of a membrane-bound form of prolyl endopeptidase. This novel activity has been isolated from the synaptosomal (plasma membranes) membranes of bovine brain. Following gel filtration, hydroxylapatite and hydrophobic interaction chromatographies, the prolyl endopeptidase activity was purified 1400-fold with a 23% recovery of activity. The enzyme was shown to have a relative molecular mass of 87 kDa and a Km of 60 microM for its specific fluorimetric substrate, Z-GlyProMCA. The purified enzyme demonstrated a relatively broad substrate specificity and a relatively high affinity for proline-containing neuropeptides. It was shown to be inhibited by certain thiol-protease inhibitors and by the metal chelator, 1,10-phenanthroline, thus possibly classifying it as a 'thimet' activity. The purified particular form of proyl endopeptidase displayed a similar substrate specificity to the previously reported cytosolic forms of the enzyme. However, there were differences between the two forms in term of their sensitivity to inhibitors, their affinities for the peptide substrates and their relative molecular masses. The different subcellular location (i.e. the synaptosomal membrane) of the particulate prolyl endopeptidase is also of potential physiological significance given that here it is more likely to come in contact with the vesicle-bound neuropeptides than is its cytosolic counterpart.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9026355     DOI: 10.1016/1357-2725(95)00154-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  10 in total

1.  Cloning and expression of a novel prolyl endopeptidase from Aspergillus oryzae and its application in beer stabilization.

Authors:  Chao Kang; Xiao-Wei Yu; Yan Xu
Journal:  J Ind Microbiol Biotechnol       Date:  2014-12-30       Impact factor: 3.346

2.  Effects of UPR and ERAD pathway on the prolyl endopeptidase production in Pichia pastoris by controlling of nitrogen source.

Authors:  Xiao-Dong Wang; Ting Jiang; Xiao-Wei Yu; Yan Xu
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-28       Impact factor: 3.346

Review 3.  Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.

Authors:  Timo T Myöhänen; J Arturo García-Horsman; Jofre Tenorio-Laranga; Pekka T Männistö
Journal:  J Histochem Cytochem       Date:  2009-05-26       Impact factor: 2.479

4.  Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.

Authors:  Peter Serfozo; Jan Wysocki; Gvantca Gulua; Arndt Schulze; Minghao Ye; Pan Liu; Jing Jin; Michael Bader; Timo Myöhänen; J Arturo García-Horsman; Daniel Batlle
Journal:  Hypertension       Date:  2019-12-02       Impact factor: 10.190

5.  Slow-binding inhibitors of prolyl oligopeptidase with different functional groups at the P1 site.

Authors:  Jarkko I Venäläinen; Risto O Juvonen; J Arturo Garcia-Horsman; Erik A A Wallén; Johannes A M Christiaans; Elina M Jarho; Jukka Gynther; Pekka T Männistö
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

Review 6.  Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.

Authors:  Uros V Djekic; Amit Gaggar; Nathaniel M Weathington
Journal:  Pharmacol Ther       Date:  2008-10-31       Impact factor: 12.310

7.  Purification and characterization of a prolyl endopeptidase isolated from Aspergillus oryzae.

Authors:  Chao Kang; Xiao-Wei Yu; Yan Xu
Journal:  J Ind Microbiol Biotechnol       Date:  2013-11-16       Impact factor: 3.346

8.  Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages.

Authors:  Swati Kaushik; Ramanathan Sowdhamini
Journal:  BMC Genomics       Date:  2014-11-18       Impact factor: 3.969

9.  Distribution of non-AT1, non-AT2 binding of 125I-sarcosine1, isoleucine8 angiotensin II in neurolysin knockout mouse brains.

Authors:  Robert C Speth; Eduardo J Carrera; Catalina Bretón; Andrea Linares; Luz Gonzalez-Reiley; Jamala D Swindle; Kira L Santos; Ines Schadock; Michael Bader; Vardan T Karamyan
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

Review 10.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.